British pharmaceutical giant AstraZeneca said on Tuesday that it aims to achieve sales of US$80 billion by 2030, nearly double from US$45.8 billion in 2023.
The company said it plans to launch 20 new drugs by 2030 to achieve its new total revenue target.
Investment bank Jefferies previously predicted that AstraZeneca\’s annual sales will exceed US$70 billion by 2031.
Astra set the target ahead of its first investor day event in 10 years.
The company\’s CEO Suboko said that he hopes to make AstraZeneca stand out in the highly competitive cancer drug market.
AstraZeneca plans to nearly double sales to $80 billion in 2030
British pharmaceutical giant AstraZeneca said on Tuesday that it aims to reach sales of $80 billion by 2030, nearly double from $45.8 billion in 2023.
Like (0)
Zoom video communications fell 1.7% before the bell, Q2 adjusted EPS guidance was lower than expected
Previous
May 21, 2024 4:04 pm
European stocks opened broadly lower, with the Stoxx Europe 50 index down 0.34%.
Next
May 21, 2024 4:04 pm